Table 3.
Minimum Detectable Hazard Ratio of the Association between Solutes and Outcomes
| Cardiac Death | Sudden Cardiac Death | First CV Event | Any-Cause Death | ||
|---|---|---|---|---|---|
| Number of Events | 221 | 127 | 641 | 563 | |
| Event Probability | 17.4% | 10.0% | 54.2% | 44.2% | |
| Solutes | Standard Deviation | HR | HR | HR | HR |
| PCS | 1.351 | 1.19 | 1.25 | 1.14 | 1.11 |
| IS | 0.930 | 1.29 | 1.40 | 1.22 | 1.17 |
| HIPP | 1.369 | 1.19 | 1.26 | 1.15 | 1.12 |
| PAG | 1.031 | 1.26 | 1.35 | 1.20 | 1.15 |
Abbreviation: HR, Hazard Ratio; PCS, P-Cresol Sulfate; IS, Indoxyl Sulfate; HIPP, Hippurate; PAG, Phenylacetylglutamine
Note: The minimum detectable hazard ratio per 2-fold increase in solute was calculated assuming 90% power and alpha=0.05. Observed standard deviation of the solutes and R2 from the linear regression of solutes on predictors in the fully adjusted model (Model 4) were calculated from the data.
Note: Variables measured at baseline: age, sex, race, Index of Coexisting Disease (ICED) severity score, cause of end-stage renal disease, residual kidney function (urinary stdKt/VUREA calculated from urinary urea clearance), adjusted protein intake, g/kg/day (ABW), fat percent, and CHO percent. Variables measured at the same timepoint as solutes: body mass index (categorized as <18, 18 to 25 and >25 kg/m2), systolic blood pressure (categorized as <130, 130–160 and >160 mm Hg), albumin, relative volume removed on dialysis, and nPCR.